JLA — Conversion To Creatinine, Creatine Class I

FDA Device Classification

FDA product code JLA covers "Conversion To Creatinine, Creatine", a Class I medical device regulated under 21 CFR 862.1210. Submissions are reviewed by the Clinical Chemistry panel. At least 2 recent 510(k) clearances have been granted under this product code.